AMA submission to the Therapeutic Goods Administration – building a more robust medicine supply

1 Jun 2021

The AMA supports the proposals by the TGA that aim to build a more robust medicine supply. The TGA should be adequately funded and resourced by the government to ensure any losses in revenue from these proposals do not result in a reduction in other TGA work. The proposals listed are a good start. However, the AMA perceives these proposals to be small in scope where there needs to be innovative, wider-ranging solutions to ensure patients receive the medicines they need, when they need them.